Axolotl Biosciences wins the Judge’s Choice Prize at the FASTPITCH Competition held at 2021 Life Science Innovation Northwest Conference

April 7th, 2021 Victoria, B.C

Axolotl Biosciences – a spin-off company from the University of Victoria  claimed the top Judge’s Pick Award during the FASTPITCH competition held at the 2021 Life Science Innovation Northwest Conference. In this competition, twelve life science early-stage companies competed for a $5,000 judges-pick prize and a $1,000 audience-pick prize. Judges David Kereiakes from Providence Ventures, Loretta Little from WA Research Fund, Alice Chen from Accelerator Life Science Partners, and Scott Maloney from Washington State University determined which 60 second pitch drives the best business opportunity and they selected Axolotl Biosciences based on their novel bioinks for generating human tissue models for drug screening.

Dr. Stephanie Willerth says “Winning the Judge’s Choice prize serves asrecognition of our unique bioink and its ability to generate human tissues for drug screening applications as well as validating the progress that Axolotl has made over the past year since incorporation”.

Dr. Dale Willard – the Business Development Manager at Life Science Washington– added “We had an outstanding crop of twelve finalists this year and Axolotl rose above them with an outstanding presentation that addresses an exploding drug development sector.”

Julie Bennion, Trade Commissioner, commented “This is a well-deserved honor for this innovative woman-led Canadian start-up. Our team at the Consulate General of Canada in Seattle is pleased to help Axolotl and other life science companies in the Pacific Northwest.”

About Axolotl Biosciences: Axolotl Biosciences supplies unique 3D bioink solutions that are compatible with multiple bioprinting platforms. Our inks incorporate both biological and printability requirements for sensitive cell types, enabling advance tissue engineering applications. Our expertise, understanding and focus on the biological needs of cells in 3D constructs distinguishes us from other matrix and bioink suppliers. We are currently driving towards the commercial launch of our initial TissuePrint bioink and anticipate having both direct sales and a distribution deal in 2021.

About Life Science Innovation Northwest (LSINW): LSINW is the Pacific Northwest’s largest annual life science conference. This live virtual one-and-a-half day event bringstogether investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community to discuss and feature some of the most compelling life science breakthroughs of our time. It was held March 30th-31st, 2021, with the recorded content available through the end of 2021 by registering at Life Science WA. 

Dr. Stephanie Willerth
C.E.O. Axolotl Biosciences